Recent policy changes help increase access to recommended non-invasive colorectal cancer screening tests. These policy changes require Medicare and most commercial insurers to pay for colonoscopy after a positive Cologuard test without cost to the patient. For most patients, these financial protections take effect starting Jan. 1.
Texas Oncology is collaborating with the American Cancer Society to improve access to cancer screening and early detection in Texas through a new, exclusive statewide collaboration. The initiative focuses on breaking down barriers to screening, raising awareness about prevention, and helping more people catch cancer early.
